01 September 2007
The Early Detection of Alcohol Consumption (EDAC) test shows better performance than Gamma-glutamyltransferase (GGT) to Detect Heavy Drinking in a large population of males and females
James Harasymiw, Pamela BeanMed Sci Monit 2007; 13(9): PI19-24 :: ID: 498416
Abstract
Background: This study compared the effectiveness of using the Early Detection of Alcohol Consumption (EDAC) test versus gamma-glutamyltransferase (GGT) to screen for heavy drinking in the general population. Alcohol use was recorded by personal interview; heavy drinking was defined as males drinking 2.5 ounces of alcohol (5 drinks) per day and females drinking 2 ounces (4 drinks) of alcohol daily.
Material/Methods: The population analyzed consisted of 1,022 males (618 heavy drinkers and 404 light drinkers) and 583 females (203 heavy drinkers and 380 light drinkers). The EDAC used 27 routine laboratory tests; a P-positive value >50% was indicative of heavy drinking. The GGT test used a cutoff of 85U/L for males and 65U/L for females.
Results: The results showed that 30% of males reporting heavy drinking tested GGT positive compared to 65% who tested EDAC positive. Specificity was 92% for GGT and 89% for EDAC. Assuming 30% heavy drinking in this population, Positive Predictive Value (PPV) for GGT was 0.62 compared to 0.71 for EDAC. For females, the results showed that 23% of those reporting heavy drinking tested GGT positive compared to 34% who tested EDAC positive. Specificity was 94% for GGT and 98% for the EDAC. PPV for GGT was 0.62 compared to 0.88 for EDAC.
Conclusions: The EDAC test identified twice as many males and 50% more female drinkers than GGT. With higher PPV, the EDAC is a better approach to screen for heavy drinking in both males and females.
Keywords: Alcohol Drinking - blood, Biological Markers, ROC Curve, Time Factors, gamma-Glutamyltransferase - metabolism
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
26 Feb 2024 : Clinical Research
Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...Med Sci Monit In Press; DOI: 10.12659/MSM.942509
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952